Chi Sheng Chemical Cash Flow Conversion Efficiency
Chi Sheng Chemical cash flow conversion efficiency. Based on the latest financial reports, Chi Sheng Chemical (4111) has a cash flow conversion efficiency ratio of 0.013x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (NT$17.35 Million ≈ $546.49K USD) by net assets (NT$1.29 Billion ≈ $40.68 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Chi Sheng Chemical (2017–2024)
Cash flow conversion efficiency of Chi Sheng Chemical from 2017 to 2024. This chart illustrates how Chi Sheng Chemical's cash flow conversion efficiency has evolved over time, based on yearly financial data. View 4111 live share price for real-time trading data and today's change.
Chi Sheng Chemical Cash Flow Conversion Ratio Explained
Chi Sheng Chemical cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Chi Sheng Chemical Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Chi Sheng Chemical ranked by their cash flow conversion efficiency. Also see 4111 market cap for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Faraday Future Intelligent Electric Inc.
NASDAQ:FFAI
|
-3.661x |
|
UIL Co. Ltd
KQ:049520
|
0.085x |
|
DYO Boya Fabrikalari Sanayi ve Ticaret AS
IS:DYOBY
|
0.068x |
|
Mackolik Internet Hizmetleri Ticaret A.S.
IS:MACKO
|
0.071x |
|
Credo Brands Marketing Limited
NSE:MUFTI
|
0.074x |
|
Aplisens SA
WAR:APN
|
0.047x |
|
Munjal Showa Limited
NSE:MUNJALSHOW
|
-0.058x |
|
Bekasi Fajar Industrial Estate
JK:BEST
|
0.001x |
Annual Cash Flow Conversion Efficiency for Chi Sheng Chemical (2017–2024)
The table below shows the annual cash flow conversion efficiency of Chi Sheng Chemical from 2017 to 2024. Review cash generation quality of Chi Sheng Chemical to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | NT$1.27 Billion ≈ $40.16 Million |
NT$213.20 Million ≈ $6.72 Million |
0.167x | +173.64% |
| 2023-12-31 | NT$1.22 Billion ≈ $38.41 Million |
NT$74.52 Million ≈ $2.35 Million |
0.061x | -65.23% |
| 2022-12-31 | NT$1.22 Billion ≈ $38.50 Million |
NT$214.86 Million ≈ $6.77 Million |
0.176x | +38.89% |
| 2021-12-31 | NT$1.10 Billion ≈ $34.68 Million |
NT$139.33 Million ≈ $4.39 Million |
0.127x | -5.13% |
| 2020-12-31 | NT$1.08 Billion ≈ $33.89 Million |
NT$143.53 Million ≈ $4.52 Million |
0.133x | -12.25% |
| 2019-12-31 | NT$1.07 Billion ≈ $33.77 Million |
NT$162.96 Million ≈ $5.13 Million |
0.152x | +39.15% |
| 2018-12-31 | NT$1.05 Billion ≈ $32.93 Million |
NT$114.19 Million ≈ $3.60 Million |
0.109x | -36.45% |
| 2017-12-31 | NT$1.05 Billion ≈ $33.19 Million |
NT$181.14 Million ≈ $5.71 Million |
0.172x | -- |
About Chi Sheng Chemical
Chi Sheng Pharma & Biotech Co., Ltd manufactures, processes, imports, exports, and sells western medicines, cosmetics, health food products, medical devices, and animal medicines in Taiwan and internationally. Its product portfolio includes antibiotics and chemotherapeutic agents; plasma substitutes and amino acid preparations; water nutrients and electrolyte preparations; vitamins; hepatotropic … Read more